Cellectis (CLLS) EBT Margin (2015 - 2026)
Cellectis' (CLLS) quarterly EBT Margin came in at 152.85% in Q1 2026, down 17504.0% year-on-year from N/an in Q1 2025, and up 81.67% quarter-over-quarter from 834.05% in Q4 2025.
Cellectis (CLLS) EBT Margin (2015 - 2026) Analysis & Trends
Cellectis' EBT Margin history runs 12 years deep, the most recent figure standing at 152.85% for Q1 2026.
- On a quarterly basis, EBT Margin fell 17504.0% year-over-year to 152.85% in Q1 2026; TTM through Mar 2026 was 109.14%, a 5924.0% decrease from a year earlier, with the FY2025 full-year figure at 93.24%, down 467.0% from the prior year.
- EBT Margin advanced to 152.85% in Q1 2026 per CLLS's latest filing, from 834.05% in the prior quarter.
- Across five years, EBT Margin topped out at 257.33% in Q1 2024 and bottomed at 31081.27% in Q4 2023.
- The 5-year median for EBT Margin is 327.64% (2024), against an average of 6106.61%.
- Across the five-year window, EBT Margin tumbled 3106357 bps in 2023 and surged 3075363 bps in 2024, its largest moves.
- Year by year, EBT Margin stood at 17.7% in 2022, then tumbled by 175454 bps to 31081.27% in 2023, then jumped by 99 bps to 327.64% in 2024, then plunged by 155 bps to 834.05% in 2025, then jumped by 82 bps to 152.85% in 2026.
- Per Business Quant, the three latest CLLS EBT Margin figures stand at 152.85% (Q1 2026), 834.05% (Q4 2025), and 63.72% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | -152.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -152.85% |
| Dec 31, 2025 | -834.05% |
| Sep 30, 2025 | 63.72% |
| Jun 30, 2025 | 93.60% |
| Mar 31, 2025 | 22.20% |
| Dec 31, 2024 | -327.64% |
| Sep 30, 2024 | 47.54% |
| Jun 30, 2024 | 97.13% |
| Mar 31, 2024 | 257.33% |
| Dec 31, 2023 | -31,081.27% |
| Sep 30, 2023 | -25,056.13% |
| Jun 30, 2023 | -19,461.80% |
| Mar 31, 2023 | -12,574.82% |
| Dec 31, 2022 | -17.70% |
| Sep 30, 2022 | -13,354.29% |
| Jun 30, 2022 | -1,195.87% |
| Mar 31, 2022 | -337.48% |
| Dec 31, 2021 | -68.77% |
| Sep 30, 2021 | -536.03% |
| Jun 30, 2021 | -323.63% |